A combination of the US drugmaker’s monoclonal antibodies bamlanivimab and etesevimab has been given approval for restricted use in emergency situations in hospital settings in adults.
from Top India News- News18.com https://ift.tt/3c7NMBb
via IFTTT
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment